| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2019 | GH Guardant Health, Inc. | Lanman Richard B. | Chief Medical Officer | Sell | 5,764 | $69.96 | $403,249.44 | -6.6% | |
| Nov 1, 2019 | WAT Waters Corp /de/ | Glimcher Laurie H M.D. | Director | Sell | 2,200 | $214.64 | $472,208.00 | -37.9% | |
| Nov 1, 2019 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 106,274 | $22.99 | $2,442,745.77 | -24.5% | |
| Oct 31, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.43 | $71,250.25 | - | |
| Oct 30, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $1.44 | $288,532.59 | - | |
| Oct 29, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $1.47 | $294,132.18 | - | |
| Oct 29, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 10,000 | $70.34 | $703,400.00 | -88.5% | |
| Oct 28, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 3,228 | $70.00 | $225,960.00 | -71.3% | |
| Oct 25, 2019 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 47,729 | $295.88 | $14,121,958.48 | -2.2% | |
| Oct 25, 2019 | OPK Opko Health, Inc. | Hsiao Jane Ph D65 | Vice Chairman &CTO | Buy | 400,000 | $1.50 | $600,000.00 | +8.5% | |
| Oct 25, 2019 | OPK Opko Health, Inc. | Pfenniger Richard C Jr62 | Director | Buy | 25,000 | $1.45 | $36,242.50 | +10.0% | |
| Oct 25, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 350,000 | $1.40 | $491,120.72 | - | |
| Oct 25, 2019 | OPK Opko Health, Inc. | Rubin Steven D68 | Executive Vp-administration | Buy | 15,000 | $1.50 | $22,500.00 | +0.3% | |
| Oct 25, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 2,000,000 | $1.50 | $3,000,000.00 | +1.2% | |
| Oct 22, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 10,000 | $66.90 | $669,036.00 | -62.9% | |
| Oct 22, 2019 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 16,091 | $27.51 | $442,728.89 | -10.9% | |
| Oct 22, 2019 | VCYT Veracyte, Inc. | Kennedy Keith | COO / CFO | Sell | 1,243 | $28.00 | $34,804.00 | -1.1% | |
| Oct 18, 2019 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 8,000 | $77.30 | $618,400.00 | -100% | |
| Oct 15, 2019 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | CFO &COO, Lab Operations | Sell | 16,800 | $79.16 | $1,329,816.00 | -18.9% | |
| Oct 10, 2019 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 8,000 | $24.50 | $196,004.80 | -7.2% | |
| Oct 1, 2019 | PRPH Prophase Labs, Inc. | Barr Jason Michael | Director | Buy | 2,870 | $1.96 | $5,625.20 | +17.7% | |
| Sep 27, 2019 | NDRA Endra Life Sciences Inc. | Wells David R. | Chief Financial Officer | Buy | 10,000 | $1.18 | $11,800.00 | +100.0% | |
| Sep 25, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $72.00 | $38,736.00 | -29.2% | |
| Sep 24, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 10,000 | $73.69 | $736,948.00 | -76.9% | |
| Sep 23, 2019 | XGN Exagen Inc. | H.i.g. Bio-Exagen, L.P. | 10% Owner | Buy | 425,000 | $14.00 | $5,950,000.00 | +33.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.